Cryoablation trials for Lung cancer

All Cryoablation trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Cryoablation for Lung cancer

• Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
  NCT06265350 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
  NCT07070700 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
  NCT04339218 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
  NCT07232433 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
  NCT06127303 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials study Cryoablation for Lung cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.